402 related articles for article (PubMed ID: 20214492)
1. Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat.
Mukherjea D; Jajoo S; Kaur T; Sheehan KE; Ramkumar V; Rybak LP
Antioxid Redox Signal; 2010 Sep; 13(5):589-98. PubMed ID: 20214492
[TBL] [Abstract][Full Text] [Related]
2. Short interfering RNA against transient receptor potential vanilloid 1 attenuates cisplatin-induced hearing loss in the rat.
Mukherjea D; Jajoo S; Whitworth C; Bunch JR; Turner JG; Rybak LP; Ramkumar V
J Neurosci; 2008 Dec; 28(49):13056-65. PubMed ID: 19052196
[TBL] [Abstract][Full Text] [Related]
3. siRNA-mediated knock-down of NOX3: therapy for hearing loss?
Rybak LP; Mukherjea D; Jajoo S; Kaur T; Ramkumar V
Cell Mol Life Sci; 2012 Jul; 69(14):2429-34. PubMed ID: 22562580
[TBL] [Abstract][Full Text] [Related]
4. NOX3 NADPH oxidase couples transient receptor potential vanilloid 1 to signal transducer and activator of transcription 1-mediated inflammation and hearing loss.
Mukherjea D; Jajoo S; Sheehan K; Kaur T; Sheth S; Bunch J; Perro C; Rybak LP; Ramkumar V
Antioxid Redox Signal; 2011 Mar; 14(6):999-1010. PubMed ID: 20712533
[TBL] [Abstract][Full Text] [Related]
5. Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea.
Kaur T; Borse V; Sheth S; Sheehan K; Ghosh S; Tupal S; Jajoo S; Mukherjea D; Rybak LP; Ramkumar V
J Neurosci; 2016 Apr; 36(14):3962-77. PubMed ID: 27053204
[TBL] [Abstract][Full Text] [Related]
6. Expression of the kidney injury molecule 1 in the rat cochlea and induction by cisplatin.
Mukherjea D; Whitworth CA; Nandish S; Dunaway GA; Rybak LP; Ramkumar V
Neuroscience; 2006 May; 139(2):733-40. PubMed ID: 16464536
[TBL] [Abstract][Full Text] [Related]
7. A novel synthetic compound, 3-amino-3-(4-fluoro-phenyl)-1H-quinoline-2,4-dione, inhibits cisplatin-induced hearing loss by the suppression of reactive oxygen species: in vitro and in vivo study.
Shin YS; Song SJ; Kang SU; Hwang HS; Choi JW; Lee BH; Jung YS; Kim CH
Neuroscience; 2013 Mar; 232():1-12. PubMed ID: 23246618
[TBL] [Abstract][Full Text] [Related]
8. Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation.
Kaur T; Mukherjea D; Sheehan K; Jajoo S; Rybak LP; Ramkumar V
Cell Death Dis; 2011 Jul; 2(7):e180. PubMed ID: 21776018
[TBL] [Abstract][Full Text] [Related]
9. Ginkgolide B protects against cisplatin-induced ototoxicity: enhancement of Akt-Nrf2-HO-1 signaling and reduction of NADPH oxidase.
Ma W; Hu J; Cheng Y; Wang J; Zhang X; Xu M
Cancer Chemother Pharmacol; 2015 May; 75(5):949-59. PubMed ID: 25749575
[TBL] [Abstract][Full Text] [Related]
10. Noise-induced changes in expression levels of NADPH oxidases in the cochlea.
Vlajkovic SM; Lin SC; Wong AC; Wackrow B; Thorne PR
Hear Res; 2013 Oct; 304():145-52. PubMed ID: 23899412
[TBL] [Abstract][Full Text] [Related]
11. Targeting CXCL1 chemokine signaling for treating cisplatin ototoxicity.
Al Aameri RFH; Alanisi EMA; Oluwatosin A; Al Sallami D; Sheth S; Alberts I; Patel S; Rybak LP; Ramkumar V
Front Immunol; 2023; 14():1125948. PubMed ID: 37063917
[TBL] [Abstract][Full Text] [Related]
12. Age-related hearing loss patterns in Fischer 344/NHsd rats with cisplatin-induced hearing loss.
Bielefeld EC
Hear Res; 2013 Dec; 306():46-53. PubMed ID: 24055622
[TBL] [Abstract][Full Text] [Related]
13. Nox3-Derived Superoxide in Cochleae Induces Sensorineural Hearing Loss.
Mohri H; Ninoyu Y; Sakaguchi H; Hirano S; Saito N; Ueyama T
J Neurosci; 2021 May; 41(21):4716-4731. PubMed ID: 33849947
[TBL] [Abstract][Full Text] [Related]
14. Transient Receptor Potential Channels and Auditory Functions.
Ramkumar V; Sheth S; Dhukhwa A; Al Aameri R; Rybak L; Mukherjea D
Antioxid Redox Signal; 2022 Jun; 36(16-18):1158-1170. PubMed ID: 34465184
[No Abstract] [Full Text] [Related]
15. Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity.
Borse V; Al Aameri RFH; Sheehan K; Sheth S; Kaur T; Mukherjea D; Tupal S; Lowy M; Ghosh S; Dhukhwa A; Bhatta P; Rybak LP; Ramkumar V
Cell Death Dis; 2017 Jul; 8(7):e2921. PubMed ID: 28703809
[TBL] [Abstract][Full Text] [Related]
16. Lovastatin protects against cisplatin-induced hearing loss in mice.
Fernandez K; Spielbauer KK; Rusheen A; Wang L; Baker TG; Eyles S; Cunningham LL
Hear Res; 2020 Apr; 389():107905. PubMed ID: 32062294
[TBL] [Abstract][Full Text] [Related]
17. Oral Administration of Clinical Stage Drug Candidate SENS-401 Effectively Reduces Cisplatin-induced Hearing Loss in Rats.
Petremann M; Tran Van Ba C; Broussy A; Romanet C; Dyhrfjeld-Johnsen J
Otol Neurotol; 2017 Oct; 38(9):1355-1361. PubMed ID: 28796092
[TBL] [Abstract][Full Text] [Related]
18. Prevention of cisplatin ototoxicity using transtympanic N-acetylcysteine and lactate.
Choe WT; Chinosornvatana N; Chang KW
Otol Neurotol; 2004 Nov; 25(6):910-5. PubMed ID: 15547419
[TBL] [Abstract][Full Text] [Related]
19. Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen.
Lynch ED; Gu R; Pierce C; Kil J
Hear Res; 2005 Mar; 201(1-2):81-9. PubMed ID: 15721563
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the protective effects of hesperetin against cisplatin-induced ototoxicity in a rat animal model.
Kara M; Türkön H; Karaca T; Güçlü O; Uysal S; Türkyılmaz M; Demirtaş S; Dereköy FS
Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():12-8. PubMed ID: 27240489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
